Cargando…
Evaluation of primary breast cancers using dedicated breast PET and whole-body PET
Metabolic imaging of the primary breast tumor with (18)F-fluorodeoxyglucose ([(18)F]FDG) PET may assist in predicting treatment response in the neoadjuvant chemotherapy (NAC) setting. Dedicated breast PET (dbPET) is a high-resolution imaging modality with demonstrated ability in highlighting intratu...
Autores principales: | Hathi, Deep K., Li, Wen, Seo, Youngho, Flavell, Robert R., Kornak, John, Franc, Benjamin L., Joe, Bonnie N., Esserman, Laura J., Hylton, Nola M., Jones, Ella F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7736887/ https://www.ncbi.nlm.nih.gov/pubmed/33318514 http://dx.doi.org/10.1038/s41598-020-78865-3 |
Ejemplares similares
-
Initial experience of dedicated breast PET imaging of ER+ breast cancers using [F-18]fluoroestradiol
por: Jones, Ella F., et al.
Publicado: (2019) -
Exploration of PET and MRI radiomic features for decoding breast cancer phenotypes and prognosis
por: Huang, Shih-ying, et al.
Publicado: (2018) -
Current Landscape of Breast Cancer Imaging and Potential Quantitative Imaging Markers of Response in ER-Positive Breast Cancers Treated with Neoadjuvant Therapy
por: Jones, Ella F., et al.
Publicado: (2020) -
Molecular Imaging in Breast Cancer: From Whole-Body PET/CT to Dedicated Breast PET
por: Koolen, B. B., et al.
Publicado: (2012) -
Effect of MR Imaging Contrast Thresholds on Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer Subtypes: A Subgroup Analysis of the ACRIN 6657/I-SPY 1 TRIAL
por: Li, Wen, et al.
Publicado: (2016)